Viridian Therapeutics (VRDN) Earnings Date & Reports

Industry: @Biotechnology

A.I. Advisor

published Earnings

VRDN is expected to report earnings to -100 cents per share on November 11

Viridian Therapeutics VRDN Stock Earnings Reports

Q3'24

Est.

$-1.01

Q2'24

Missed

by $0.15

Q1'24

Beat

by $0.30

Q4'23

Missed

by $0.37

Q3'23

Beat

by $0.16

The last earnings report on August 08 showed earnings per share of -101 cents, missing the estimate of -87 cents. With 1.42M shares outstanding, the current market capitalization sits at 1.78B.

View a ticker or compare two or three

Compare

VRDN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For VRDN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for VRDN (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

221 Crescent Street

Phone

+1 617 272-4600

Employees

Web

https://www.viridiantherapeutics.com